Summit Therapeutics

SMMTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$11.137 B

$13.96 +3.10%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$1.08B

Loss-making

Shares outstanding

797,749,602

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#31Madrigal PharmaceuticalsMDGL$11.8B
#32AbivaxABVX$11.3B
#33Summit TherapeuticsSMMT$11.1B
#34Elanco Animal HealthELAN$11.1B
#35Axsome TherapeuticsAXSM$10.9B

Where these numbers come from

Share counts and financials for Summit Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.